A detailed history of Ars Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ars Investment Partners, LLC holds 22,604 shares of BMY stock, worth $896,474. This represents 0.13% of its overall portfolio holdings.

Number of Shares
22,604
Previous 22,350 1.14%
Holding current value
$896,474
Previous $1.15 Million 6.89%
% of portfolio
0.13%
Previous 0.14%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $12,186 - $13,817
254 Added 1.14%
22,604 $1.23 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $73,932 - $88,221
-1,525 Reduced 6.39%
22,350 $1.15 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $46,312 - $51,784
-800 Reduced 3.24%
23,875 $1.39 Million
Q2 2023

Jul 11, 2023

SELL
$63.71 - $70.74 $32,874 - $36,501
-516 Reduced 2.05%
24,675 $1.58 Million
Q1 2023

Apr 05, 2023

BUY
$65.71 - $74.53 $114,006 - $129,309
1,735 Added 7.4%
25,191 $1.75 Million
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $957,692 - $1.13 Million
-13,985 Reduced 37.35%
23,456 $0
Q3 2022

Oct 07, 2022

BUY
$0.13 - $76.84 $1,761 - $1.04 Million
13,550 Added 56.72%
37,441 $2.66 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $24,592 - $29,488
400 Added 1.7%
23,891 $1.75 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $100,288 - $116,912
-1,870 Reduced 7.37%
23,491 $1.47 Million
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $2.29 Million - $2.49 Million
-36,959 Reduced 59.31%
25,361 $1.7 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $5,696 - $6,407
-96 Reduced 0.15%
62,320 $3.93 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $15,358 - $17,404
266 Added 0.43%
62,416 $3.87 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $87,810 - $97,305
1,529 Added 2.52%
62,150 $3.75 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $1.67 Million - $1.96 Million
30,548 Added 101.58%
60,621 $3.57 Million
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $13,920 - $20,229
-300 Reduced 0.99%
30,073 $1.68 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $89,808 - $117,146
1,825 Added 6.39%
30,373 $1.95 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $653,097 - $774,341
-15,270 Reduced 34.85%
28,548 $1.45 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $447,627 - $494,978
10,032 Added 29.69%
43,818 $1.99 Million
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $7.08 Million - $8.44 Million
-156,874 Reduced 82.28%
33,786 $1.61 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $606,623 - $786,644
-12,441 Reduced 6.13%
190,660 $9.91 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $94,319 - $106,385
1,709 Added 0.85%
203,101 $12.6 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $1.39 Million - $1.73 Million
-27,434 Reduced 11.99%
201,392 $11.1 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $236,803 - $272,608
3,952 Added 1.76%
228,826 $14.5 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $83,916 - $91,489
-1,400 Reduced 0.62%
224,874 $13.8 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $12.5 Million - $14.4 Million
226,274
226,274 $14.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.